On 2015 May 21, ALEXANDER TSAI commented:
The measures of n-3 and n-6 PUFA intake used in this study have well documented construct validity, as supported by moderate-to-strong correlations with fatty acids measured in plasma and erythrocytes and adipose tissue, and by their ability to predict the incidence of relevant conditions such as coronary heart disease, type 2 diabetes, and macular degeneration. The experimental evidence for the use of n-3 in the treatment of depression is not conclusive. In the meta-analysis by Bloch & Hannestad (Mol Psych 2012;17:1272–1282), the estimated treatment effect was small in magnitude and not statistically significant. Even if one accepts the criticisms that were published in response to that study, the reanalyses (Mol Psych 2012;17:1163–1167) did not change the fundamental conclusion that any possible measurable effect of n-3 on depression is small and likely explained by publication bias.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.